Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 18, 2015Journal of Bone and Mineral ResearchOpen Access

Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways

View Full Paper
Ask AI
Bookmark
Share

Authors

LZLin ZhouNanjing Agricultural UniversityQLQian LiuCentral South UniversityMYMingli YangZunyi Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhou et al. (2015) studied this question.

synapsesocial.com/papers/69da6bcba6045d71bfa3cafehttps://doi.org/10.1002/jbmr.2771
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL1998 · 4,285 citations
  2. 2Artemisinins: their growing importance in medicine2008 · 390 citations
  3. 3Osteolysis and cancer2001 · 80 citations